相似文献
1
An algorithm for genetic testing of frontotemporal lobar degeneration.
Neurology. 2011 Feb 1;76(5):475-83. doi: 10.1212/WNL.0b013e31820a0d13.
2
[Pathomechanisms and clinical aspects of frontotemporal lobar degeneration].
Nervenarzt. 2017 Feb;88(2):163-172. doi: 10.1007/s00115-016-0259-x.
3
Genetics of frontotemporal lobar degeneration: an up-date and diagnosis algorithm.
Rev Neurol (Paris). 2013 Oct;169(10):811-9. doi: 10.1016/j.neurol.2013.07.014. Epub 2013 Sep 4.
4
Identification of 2 Loci at chromosomes 9 and 14 in a multiplex family with frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Arch Neurol. 2010 May;67(5):606-16. doi: 10.1001/archneurol.2010.82.
5
The Heritability of Frontotemporal Lobar Degeneration: Validation of Pedigree Classification Criteria in a Northern Italy Cohort.
J Alzheimers Dis. 2018;61(2):753-760. doi: 10.3233/JAD-170661.
6
Genetics of Frontotemporal Lobar Degeneration: From the Bench to the Clinic.
J Alzheimers Dis. 2016 Apr 19;52(4):1157-76. doi: 10.3233/JAD-160236.
7
The neuroimaging signature of frontotemporal lobar degeneration associated with Granulin mutations: an effective connectivity study.
J Nucl Med. 2013 Jul;54(7):1066-71. doi: 10.2967/jnumed.112.111773. Epub 2013 May 17.
8
TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers.
Neurology. 2011 Feb 1;76(5):467-74. doi: 10.1212/WNL.0b013e31820a0e3b. Epub 2010 Dec 22.
9
Mutations in CHMP2B are not a cause of frontotemporal lobar degeneration in Finnish patients.
Eur J Neurol. 2010 Nov;17(11):1393-5. doi: 10.1111/j.1468-1331.2010.03028.x.
10
Clinicopathological and genetic correlates of frontotemporal lobar degeneration and corticobasal degeneration.
J Neurol. 2008 Apr;255(4):488-94. doi: 10.1007/s00415-008-0565-8. Epub 2008 Mar 25.
引用本文的文献
1
Differentiating sporadic frontotemporal dementia from late-onset primary psychiatric disorders.
Brain Commun. 2025 May 22;7(3):fcaf199. doi: 10.1093/braincomms/fcaf199. eCollection 2025.
2
Serum neurofilament light is superior to glial fibrillary acidic protein to distinguish sporadic frontotemporal dementia from late-onset primary psychiatric disorders: a retrospective DIPPA-FTD study.
BMJ Neurol Open. 2025 Jun 1;7(1):e001007. doi: 10.1136/bmjno-2024-001007. eCollection 2025.
3
Prevalence of Pathogenic Variants and Eligibility Criteria for Genetic Testing in Patients Who Visit a Memory Clinic.
Neurology. 2025 Feb 25;104(4):e210273. doi: 10.1212/WNL.0000000000210273. Epub 2025 Jan 27.
4
Apraxia phenotypes and frontotemporal lobar degeneration.
J Neurol. 2024 Dec;271(12):7471-7488. doi: 10.1007/s00415-024-12706-5. Epub 2024 Oct 10.
5
Phase 1 study of latozinemab in progranulin-associated frontotemporal dementia.
Alzheimers Dement (N Y). 2024 Jan 31;10(1):e12452. doi: 10.1002/trc2.12452. eCollection 2024 Jan-Mar.
6
Rationale and Design of the "DIagnostic and Prognostic Precision Algorithm for behavioral variant Frontotemporal Dementia" (DIPPA-FTD) Study: A Study Aiming to Distinguish Early Stage Sporadic FTD from Late-Onset Primary Psychiatric Disorders.
J Alzheimers Dis. 2024;97(2):963-973. doi: 10.3233/JAD-230829.
7
Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia.
J Transl Med. 2023 Jun 15;21(1):387. doi: 10.1186/s12967-023-04251-y.
8
Frontotemporal dementia: A unique window on the functional role of the temporal lobes.
Handb Clin Neurol. 2022;187:429-448. doi: 10.1016/B978-0-12-823493-8.00011-0.
9
Genetic Counselling Improves the Molecular Characterisation of Dementing Disorders.
J Pers Med. 2021 May 26;11(6):474. doi: 10.3390/jpm11060474.
10
Tauopathy and Movement Disorders-Unveiling the Chameleons and Mimics.
Front Neurol. 2020 Nov 5;11:599384. doi: 10.3389/fneur.2020.599384. eCollection 2020.
本文引用的文献
1
Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family.
J Neurol Neurosurg Psychiatry. 2011 Feb;82(2):196-203. doi: 10.1136/jnnp.2009.204081. Epub 2010 Jun 20.
2
FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration.
Acta Neuropathol. 2010 Jul;120(1):33-41. doi: 10.1007/s00401-010-0698-6. Epub 2010 May 20.
3
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions.
Nat Genet. 2010 Mar;42(3):234-9. doi: 10.1038/ng.536. Epub 2010 Feb 14.
4
Alzheimer disease-like phenotype associated with the c.154delA mutation in progranulin.
Arch Neurol. 2010 Feb;67(2):171-7. doi: 10.1001/archneurol.2010.113.
5
The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration.
Arch Neurol. 2010 Feb;67(2):161-70. doi: 10.1001/archneurol.2009.328.
6
Genetic contribution of FUS to frontotemporal lobar degeneration.
Neurology. 2010 Feb 2;74(5):366-71. doi: 10.1212/WNL.0b013e3181ccc732.
7
Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations.
Neuroimage. 2010 Nov 15;53(3):1070-6. doi: 10.1016/j.neuroimage.2009.12.088. Epub 2010 Jan 4.
8
Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration.
J Neurol. 2010 May;257(5):747-53. doi: 10.1007/s00415-009-5404-z. Epub 2009 Nov 28.
9
Prediction of pathology in primary progressive language and speech disorders.
Neurology. 2010 Jan 5;74(1):42-9. doi: 10.1212/WNL.0b013e3181c7198e. Epub 2009 Nov 25.
10
The heritability and genetics of frontotemporal lobar degeneration.
Neurology. 2009 Nov 3;73(18):1451-6. doi: 10.1212/WNL.0b013e3181bf997a.
Zotero 插件